“The goal is always to better manage opioid usage from the onset of treatment,” said Phil Walls, R.Ph., Chief Clinical and Compliance Officer at myMatrixx.
Tampa, FL (Vocus/PRWEB) March 03, 2011
myMatrixx® has announced significant enhancements to its highly successful Opioid Management Program, offering clients, injured patients, and physicians added tools for dealing with the increased use of opioids in workers’ compensation.
Improvements to the program focus on helping all stakeholders to better manage opioid therapy from the date of injury forward using evidence-based pain management guidelines.
Embedded within the company’s already established Alert, Review, and Manage (ARM) ™ capability, the Opioid Management Program now has enhanced triggers that alert appropriate stakeholders to prescribing patterns that may indicate that opioid use is not optimally managed. This is expected to augment the momentous reduction of opioids already produced by the program. For example: Actiq® has been virtually eliminated from use with our injured patients, accounting for less than .046% of all medications, and opioid use is down 16.2% vs. industry benchmarks.
Specific triggers include: premature use of opioids in opioid-naïve patients, off-label use of opioids intended only for end-stage cancer pain, inappropriate use of long-acting opioids at the onset of treatment, use of name brand opioid medications with no valid health reason, multiple opioid prescriptions or the use of multiple prescribers or pharmacies, and other proprietary clinical edits.
“The goal is always to better manage opioid usage from the onset of treatment,” said Phil Walls, R.Ph., Chief Clinical and Compliance Officer at myMatrixx. “We believe that every dispensing event that includes opioids is an indication of either appropriate or inappropriate use. By analyzing a claim via our advanced technology and predictive modeling database, everyone in the process is alerted immediately, and the system begins the process of reviewing an injured patient for issues.”
The company’s Opioid Management Program is made more robust with the development of patient-specific recommendations based on appropriateness of therapy and guidelines such as the Official Disability Guidelines (ODG). myMatrixx clinical staff can then provide physicians with detailed information for making improvements in opioid therapy, such as conversion dosages for alternative opioids with better therapeutic profiles and weaning guides, when required.
myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the “Customer Experience.” The company’s Technology Plus™ platform and approach combines advanced technology, expert clinical support, productivity-improving processes, real-time alerts and comprehensive reporting to simplify the management of worker’s compensation claims. The result is a reduction of costs and improved outcomes for clients and their injured workers.